Institutions / Lion Point Capital, LP / Holdings
Back to Lion Point Capital, LP

Lion Point Capital, LP

All holdings · as of Dec 31, 2025

39 positions

CompanyClassValueShares% of portfolio
Milestone Pharmaceuticals Inc.—$1.53M755,0007.9%
Praxis Precision Medicines, Inc.—$1.31M4,4506.8%
MoonLake ImmunotherapeuticsMLTXCommon Stock$889.6K67,5004.6%
FENNEC PHARMACEUTICALS INC.—$865.7K112,4344.5%
JASPER THERAPEUTICS INCJSPRCommon Stock$851.0K465,0004.4%
Benitec Biopharma Inc.BNTCCommon Stock$835.1K62,0004.3%
ROYALTY PHARMA PLC—$826.9K21,4004.3%
GERON CORP—$763.0K578,0003.9%
Syndax Pharmaceuticals Inc—$756.4K36,0003.9%
ARDELYX, INC.—$750.0K128,6503.9%
CUE BIOPHARMA INC—$672.8K2,202,8543.5%
Disc Medicine, Inc.IRONCommon Stock$643.2K8,1003.3%
Sarepta Therapeutics, Inc.—$613.3K28,5003.2%
Biohaven Ltd.—$583.7K51,7003.0%
HUMACYTE INC—$480.3K500,0002.5%
Kura Oncology, Inc.—$477.9K46,0002.5%
Seres Therapeutics, Inc.MCRBCommon Stock$469.8K31,5702.4%
COMPASS Pathways plcCMPSADR$400.2K58,0002.1%
Day One Biopharmaceuticals, Inc.—$391.4K42,0002.0%
REGENXBIO Inc.—$383.0K26,6002.0%
BridgeBio Pharma, Inc.—$382.4K5,0002.0%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$381.0K10,5002.0%
Ventyx Biosciences, Inc.—$374.7K41,5001.9%
Lantheus Holdings, Inc.—$366.0K5,5001.9%
Dyne Therapeutics, Inc.—$352.1K18,0001.8%
UNIQURE NV—$351.8K14,7001.8%
Pacira BioSciences Inc—$349.4K13,5001.8%
Viatris Inc—$344.9K27,7001.8%
Azenta Inc—$322.6K9,7001.7%
ROCKET PHARMACEUTICALS, INC.—$301.9K86,0001.6%
Janux Therapeutics, Inc.—$262.2K19,0001.4%
Edgewise Therapeutics, Inc.—$225.8K9,1001.2%
Innoviva Inc—$163.9K8,2000.8%
Arcutis Biotherapeutics, Inc.—$152.5K5,2500.8%
INNATE PHARMA S A—$142.0K81,1510.7%
MINERVA NEUROSCIENCES, INC.—$140.7K35,0000.7%
GH RESEARCH PLC—$129.5K10,2000.7%
SPRUCE BIOSCIENCES, INC.SPRBCommon Stock$87.1K1,0000.5%
MERSANA THERAPEUTICS INC—$2.9K1000.0%
← PrevPage 1 of 1Next →